-
Signature
-
/s/ Timothy C. Dec, as attorney-in-fact
-
Issuer symbol
-
SUPN
-
Transactions as of
-
24 Feb 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
25 Feb 2026, 16:56:53 UTC
Quoteable Key Fact
"Frederick M. Hudson filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 25 Feb 2026."
Quick Takeaways
- This page summarizes Frederick M. Hudson's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 25 Feb 2026, 16:56.
What Changed
- Previous filing in this sequence was filed on 20 Feb 2026.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Hudson Frederick M. |
Director |
C/O SUPERNUS PHARMACEUTICALS, INC.,, 9715 KEY WEST AVENUE, ROCKVILLE |
/s/ Timothy C. Dec, as attorney-in-fact |
25 Feb 2026 |
0001438462 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SUPN |
Common Stock |
Award |
$0 |
+4,475 |
+7.3% |
$0.000000 |
65,782 |
24 Feb 2026 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SUPN |
Restricted Stock Unit |
Disposed to Issuer |
$0 |
-4,475 |
-100% |
$0.000000 |
0 |
24 Feb 2026 |
Common Stock |
4,475 |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: